Highlights of ASH in Asia-Pacific
Thank You for Your Attendance!
This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.
We extend our heartfelt thanks to all attendees for making the 2024 Highlights of ASH in Asia-Pacific a success.
Stay tuned for future updates!
Join the world's leading hematology experts at Highlights of ASH in Asia-Pacific, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and non-malignant hematology.
By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.
Through participation in this meeting, you will be able to:
- Recap stand-out abstracts from the most recent ASH annual meeting.
- Discuss rapidly evolving developments in hematology and hematology-oncology with leading faculty in the field.
- Participate in interactive panel discussions and attend small group lunch sessions with the experts.
- Improve therapeutic and overall practice methods.
- Discover new treatments for patients.
This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.
Program Co-Host
ASH is proud to co-host this meeting with the Haematology Society of Australia and New Zealand.
Program Schedule
| 8:00 a.m. | Registration and Exhibition Opens |
| 8:45 a.m. | Welcome & Morning Session |
| 9:00 a.m. | Clonal Hematopoiesis and Myelodysplastic Syndromes Radhika Gangaraju, MD University of Alabama at Birmingham |
| 9:30 a.m. | Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia David Ross, PhD Flinders Medical Centre |
| 10:00 a.m. | Panel Discussion |
| 10:30 a.m. | Coffee Break and Exhibition |
| 11:00 a.m. | Autoimmunity and Complement Disorders Hanny Al-Samkari, MD Harvard University |
| 11:30 a.m. | Inherited Bleeding Disorders Tyler Buckner, MD University of Colorado, Denver |
| 12:00 p.m. | Panel Discussion |
| 12:30 p.m. | Lunch with the Experts Session |
| 1:30 p.m. | Special Education Session: Hematology in Special Groups Julie Jaffray, MD Rady Children's Hospital, San Diego Michelle Sholzberg, MDCM St. Michael's Hospital Yazan Abou-Ismail, MD University of Utah |
| 2:30 p.m. | Nosocomial Hematological Complications Lana Castellucci, MD University of Ottawa |
| 3:00 p.m. | Panel Discussion |
| 3:30 p.m. | Coffee Break and Exhibition |
| 4:00 p.m. | Diagnosis, Management, and Treatment of VTE Neil Zakai, MD University of Vermont |
| 4:30 p.m. | Hemoglobinopathies John Rasko, AO Centenary Institute Royal Prince Alfred Hospital |
| 5:00 p.m. | Panel Discussion |
| 5:30 p.m. | Highlights of ASH Day 1 Program Adjournment |
| 6:00 p.m. |
Satellite Symposia: Addressing the Challenges of Inhibitors in Haemophilia: A New Era in Non-Factor Replacement Therapy Unfolding Advanced Light Chain (AL) Amyloidosis: From Diagnostic Challenges to Emerging Therapies How I approach CLL and MCL treatment in the Era of Novel Therapies (an Australian View) |
| 8:00 a.m. | Registration and Exhibition Opens |
| 8:45 a.m. | Welcome and Introductions |
| 9:00 a.m. | Transfusion Medicine: Blood Banking and Apheresis Erica Wood, AO Monash University |
| 9:30 a.m. | Hematopoietic Stem Cell Transplantation John Magenau, MD University of Michigan |
| 10:00 a.m. | Panel Discussion |
| 10:30 a.m. | Coffee Break and Exhibition |
| 11:00 a.m. | Special Education Session: CAR T- Cell Therapy Matthew Frank, MD Stanford University Loretta Nastoupil, MD MD Anderson Cancer Center Robin Sanderson, PhD King's College London |
| 12:30 p.m. | Lunch with the Experts Session |
| 1:30 p.m. | Aggressive Non-Hodgkin Lymphoma (Including CAR T-cell Therapy) Laurie Sehn, MD University of British Columbia |
| 2:00 p.m. |
Low-Grade Lymphoma (Including Chronic Lymphoid Leukemia) Adam Kittai, MD Ohio State University |
| 2:30 p.m. | Panel Discussion |
| 3:00 p.m | Coffee Break and Exhibition |
| 3:30 p.m. | Acute Lymphoblastic Leukemia William Stevenson, PhD Royal North Shore Hospital |
| 4:00 p.m. | Acute Myeloid Leukemia Andrew Wei, PhD Peter Maccallum Cancer Centre |
| 4:30 p.m. | Myeloma & Plasma Cell Dyscrasia P. Joy Ho, MBBS, DPhil Royal Prince Alfred Hospital University of Sydney |
| 5:00 p.m. | Panel Discussion |
| 5:30 p.m | Meeting Adjournment |